West Pharmaceutical Services | WST - Zinsaufwendungen Für Schuld

Aktienkurs
265.93
Täglich Wechseln
6.58 2.54%
Monatlich
7.20%
Jährlich
30.66%
Q2 Prognose
247.13




Zinsaufwendungen Für Schuld Veränderung Datum
Align Technology USD 2M 660K 2023-03
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Cerus USD 2.33M 96K 2024-06
Charles River Laboratories USD 23.78M 1.63M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
Dentsply International USD 22M 1000K 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
ICU Medical USD 20.64M 21.39M 2025-12
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
IQVIA Holdings USD 193M 4M 2025-12
J&J USD 18M 290M 2025-09
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Neogen USD 14.26M 1.26M 2025-09
OraSure Technologies 1.67M 1.13M 2025-12
Quidel USD 5.68B 5.63B 2025-09
Repligen USD 5.5M 81K 2025-12
Rockwell Medical USD 232K 199K 2024-06
Solventum Corp USD 51M 13.92B 2025-12
STAAR Surgical USD 800K 799K 2025-09
Terumo JPY 463M 445M 2025-12
West Pharmaceutical Services USD 200K 100K 2025-09